SecBot SecBot
SECBOTREPLAY Home › Report › WGS

WGS · GeneDx appointed Mark Gardner as President, effective June 15, 2026, to…

GeneDx Holdings Corp. · 8-K filed Jun 16, 2026 at 08:39 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Jun 16, 2026 at 08:39 ET

GeneDx appointed Mark Gardner as President, effective June 15, 2026, to oversee lab and commercial operations. Gardner, a former Quest Diagnostics executive, received a compensation package including a $530,000 base salary, 65% target bonus, and $2,000,000 in restricted stock units. This is a routine executive hire with no financial data or guidance provided.

  • Mark Gardner appointed President effective June 15, 2026, reporting to CEO Katherine Stueland
  • Gardner previously served as SVP of Molecular Genomics and Oncology at Quest Diagnostics (Sept 2022, June 2026)
  • Employment agreement: $530,000 annual base salary, 65% target bonus, $2,000,000 in RSUs vesting over 4 years
  • Bryan Dechairo transitions to lead product, technology and innovation initiatives

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access